GLP-1 Diary – Injection Log

GLP-1 injections, the pill and pregnancy: what the MHRA advises in 2026

UK advice: use effective contraception on GLP-1 medicines; on Mounjaro add a barrier method if you take the pill. Stop before trying to conceive. The details.

GLP-1 medicines such as Wegovy, Ozempic, Saxenda and Mounjaro must not be used during pregnancy, while trying to get pregnant or while breastfeeding, according to UK regulator guidance. If you could get pregnant, use effective contraception. If you take Mounjaro and rely on the pill, the MHRA advises adding a non-oral method such as condoms, particularly for four weeks after starting and after every dose increase.

That advice made headlines in June 2025, but many people starting treatment in 2026 still have not heard it. Here is what it says, why Mounjaro is singled out, and how to plan around it.

What the MHRA said, and why

On 5 June 2025 the MHRA issued a public reminder as part of its wider "one stop shop" guidance on GLP-1 medicines. The key points:

  • These medicines should not be taken during pregnancy, when trying to get pregnant, or when breastfeeding, because there is not enough safety data to know whether they could harm a baby.
  • Anyone who becomes pregnant while using them should speak to a healthcare professional and stop the medicine as soon as possible.
  • Effective contraception includes the pill and non-oral methods such as the implant, the coil or condoms.
  • Mounjaro is the exception for the pill: it may reduce the effectiveness of oral contraceptives in people who are overweight, so a non-oral method should be added.
  • In some cases contraception is needed for up to two months between stopping the medicine and trying to conceive.

The MHRA pointed out that this advice was already in the patient leaflets. The reminder was needed because many people simply had not read that part.

Why Mounjaro and the pill?

GLP-1 and dual GIP/GLP-1 medicines slow down how quickly the stomach empties. That can change how fast and how much of a tablet is absorbed. The EU Mounjaro product information describes a study in which a single 5 mg dose reduced the peak levels of the hormones in a combined pill by more than half and the overall exposure by about a fifth.

The EU text concludes that this single-dose effect is not considered clinically relevant. The UK regulator takes a more cautious line for people who are overweight, especially in the first weeks and after dose increases, when the effect on the stomach is strongest. If you live in the UK, follow the MHRA and NHS advice and discuss your method with your prescriber or a sexual health service.

The NHS tirzepatide page puts it in practical terms: use a barrier method such as condoms, a diaphragm or a cap for four weeks after starting and for four weeks after each dose increase.

What about vomiting and diarrhoea?

Separately from the Mounjaro interaction, any severe vomiting or diarrhoea can affect how well the pill works. Your pill leaflet explains what to do in that situation. Stomach side effects are common on all GLP-1 medicines, particularly after a dose increase, so this is worth checking whichever medicine you take.

Methods at a glance

Method On Wegovy / Ozempic / Saxenda On Mounjaro
Combined or progestogen-only pill Counted as effective by the MHRA Add a barrier method; NHS says 4 weeks after starting and after each increase
Implant, coil (IUD/IUS), injection Non-oral, not affected by stomach emptying Non-oral, not affected by stomach emptying
Condoms, diaphragm, cap Effective when used correctly every time Recommended as the add-on to the pill

This is not a recommendation of a particular method. A GP, practice nurse or sexual health clinic can help you choose what suits you.

Planning a pregnancy

If you want to try for a baby, the timing matters because these medicines stay in the body for weeks after the last dose.

  • Semaglutide (Wegovy, Ozempic): the Wegovy product information says to stop at least 2 months before a planned pregnancy because of its long half-life.
  • Tirzepatide (Mounjaro): the EU product information says at least 1 month. The NHS page says to stop at least 4 weeks before trying.

Keep using contraception during that gap. Talk to your prescriber before stopping, so you can plan what happens to your weight management and, if you have type 2 diabetes, your blood sugar treatment.

If you find out you are pregnant

Do not panic, and do not wait. The MHRA says to contact a healthcare professional and stop the medicine as soon as possible. Tell them the name of the medicine, your dose and roughly when you took the last injection. A dated injection log is useful here; GLP-1 Diary keeps one, but your pharmacy's dispensing record or your own notes do the same job.

The MHRA also encourages reporting suspected side effects, including pregnancies that happen while using these medicines, through the Yellow Card scheme.

Breastfeeding

UK guidance says GLP-1 medicines should not be used while breastfeeding. The current EU Mounjaro leaflet says tirzepatide passes into breast milk in very low amounts and asks people to talk to their doctor before using or continuing it while breastfeeding. Product information can change, so ask your doctor or health visitor for the advice that applies to you now.

Bought outside a pharmacy?

The same MHRA guidance stresses that these medicines must not be bought from beauty salons, social media or anywhere without a prior consultation, and that doing so is illegal. Unregulated products can contain the wrong amount of medicine or something else entirely, which makes contraception and pregnancy advice impossible to apply safely. See our guide on buying GLP-1 medicines safely in the UK.

Summary

  • No GLP-1 medicine during pregnancy, when trying to conceive, or when breastfeeding (UK advice).
  • Use effective contraception. On Mounjaro, add a barrier method to the pill, especially in the first 4 weeks and after each increase.
  • Stop semaglutide at least 2 months and tirzepatide at least 1 month before a planned pregnancy, with your prescriber's input.
  • Pregnant unexpectedly? Contact a healthcare professional and stop as soon as possible.

For other safety topics, see GLP-1 side effects and when to get help.

GLP-1 Diary – Injection Log

Injection sites, weight, side effects and a clear report for your doctor or nurse.

Download on the App Store

Frequently asked questions

Does Mounjaro stop the pill from working?

The MHRA says Mounjaro may reduce the effectiveness of oral contraceptives in people who are overweight, and advises adding a non-oral method such as condoms, especially in the four weeks after starting and after each dose increase.

How long before trying for a baby should I stop?

The EU product information says semaglutide (Wegovy, Ozempic) should be stopped at least 2 months before a planned pregnancy, and tirzepatide (Mounjaro) at least 1 month before. Plan the timing with your prescriber.

I just found out I am pregnant. What now?

The MHRA says to speak to a healthcare professional and stop the medicine as soon as possible. Do not wait until your next routine appointment.

Sources

  1. Women on 'skinny jabs' must use effective contraception, MHRA urges in latest guidance — MHRA (2025-06-05)
  2. Tirzepatide – pregnancy, breastfeeding and contraception — NHS
  3. Wegovy – EPAR product information, section 4.6 — European Medicines Agency
  4. Mounjaro – EPAR product information, sections 4.5 and 4.6 — European Medicines Agency
  5. GLP-1 medicines for weight loss and diabetes: what you need to know — MHRA

More articles